Clinuvel Pharmaceuticals Ltd
ASX:CUV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Clinuvel Pharmaceuticals Ltd
Clinuvel Pharmaceuticals Ltd
Total Current Liabilities
Clinuvel Pharmaceuticals Ltd
Total Current Liabilities Peer Comparison
IMM
MSB
CSL
TLX
PYC
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Total Current Liabilities
AU$29.4m
|
CAGR 3-Years
51%
|
CAGR 5-Years
63%
|
CAGR 10-Years
32%
|
|
|
Immutep Ltd
ASX:IMM
|
Total Current Liabilities
AU$6.6m
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Total Current Liabilities
$31.4m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Total Current Liabilities
$4.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
20%
|
CAGR 10-Years
20%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Total Current Liabilities
AU$157.4m
|
CAGR 3-Years
99%
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Total Current Liabilities
AU$8.6m
|
CAGR 3-Years
95%
|
CAGR 5-Years
39%
|
CAGR 10-Years
26%
|
See Also
What is Clinuvel Pharmaceuticals Ltd's Total Current Liabilities?
Total Current Liabilities
29.4m
AUD
Based on the financial report for Dec 31, 2023, Clinuvel Pharmaceuticals Ltd's Total Current Liabilities amounts to 29.4m AUD.
What is Clinuvel Pharmaceuticals Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
32%
Over the last year, the Total Current Liabilities growth was 65%. The average annual Total Current Liabilities growth rates for Clinuvel Pharmaceuticals Ltd have been 51% over the past three years , 63% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
